Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
09/2004
09/30/2004WO2004069365A8 Diagnostic imaging agents with mmp inhibitory activity
09/30/2004WO2004062568A3 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent
09/30/2004WO2003048328A9 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
09/30/2004US20040192705 Radiolabeled neuropeptide y y5 receptor antagonists
09/30/2004US20040191328 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia
09/30/2004US20040191307 Therapeutic liposome composition and method of preparation
09/30/2004US20040191250 Targeting conjugate with entrapped drug comprising lipid with polar head and hydrophobic tail attached to hydrophilic polymer and a targeting ligand to polymer; incubation; target-cell sensitized
09/30/2004US20040191249 Exposing tumor to ionizing radiation; administering drug library; isolating binding drug; cancer diagnosis; drug screening
09/30/2004US20040191248 Antibody therapy
09/30/2004US20040191174 Rhenium and technetium complexes containing a hypoxia-localizing moiety
09/30/2004US20040191169 Reducing nephrotoxicity from alpha particles emitting daughter of actinium-225 during radioimmunotherapyfor cancer treatment
09/30/2004CA2519315A1 Radiolabeled conjugates based on substance p and the uses thereof
09/29/2004EP1463065A1 Processes for producing 15o-carbon monoxide and 15o-carbon dioxide and production apparatus
09/29/2004EP1462119A1 Modulators of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics
09/29/2004EP1461360A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
09/29/2004EP1461122A2 Treatment of genitourinary tract disorders
09/29/2004EP1461082A2 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
09/29/2004EP1461020A1 Synthesis of small particles
09/29/2004EP1461001A2 Cancer-associated epitope
09/29/2004EP1192166B1 Group(vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them
09/29/2004EP1178838B1 Macromolecular carrier based on dextran for drug and diagnostic agent delivery
09/29/2004EP1105164A4 Imaging with tc-99m labeled fibrin-alpha-chain peptide
09/29/2004EP0912533B1 Alkylaminobenzothiazole and -benzoxazole derivatives
09/29/2004EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials
09/29/2004CN1533381A Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
09/29/2004CN1533286A Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
09/29/2004CN1168741C Monoclonal antibody anti alpha; V-integrin and it use to inhibit alpha; beta; 6-integrain attachment to fibronectine
09/28/2004US6797702 Methods and compositions comprising DNA damaging agents and P53
09/23/2004WO2004081051A1 Bispecific antibodies
09/23/2004WO2004081031A2 Thiol-mediated drug attachment to targeting peptides
09/23/2004WO2004080492A1 Methods of radiofluorination of biologically active vectors
09/23/2004WO2004080335A2 Method for continuous visualization of a body lumen
09/23/2004WO2004065407A3 Improved gastrin releasing peptide compounds
09/23/2004WO2004056399A3 Solid-phase fluorination of benzothiazoles
09/23/2004WO2004050707A3 Tumor-specific recognition molecules
09/23/2004WO2004039842A3 Humanized tissue factor antibodies
09/23/2004WO2004024877A3 Human kininogen d3 domain polypeptide as an anti-angiogenic and anti-tumor agent
09/23/2004WO2004016231A3 PROTECTION OF PATIENTS LACKING A FUNCTIONAL SPLEEN AGAINST S. PNEUMONIAE WITH PNEUMOCOCCAL SURFACE PROTEIN A (PspA)
09/23/2004US20040186312 Solid-phase electrophilic fluorination
09/23/2004US20040185510 Administering a composition sufficient for external imaging, a peptide of given formula; radioactive scanning or by magnetic resonance; use for detecting metastasis; kits
09/23/2004US20040184990 Receptor binding conjugates
09/23/2004US20040184989 needle comprises a shaft comprising a plurality of outlets therein and a closed sharp tip, such that a substance injected from said device is radially distributed in a volume of tissue
09/23/2004CA2518889A1 Methods of radiofluorination of biologically active vectors
09/23/2004CA2518406A1 Thiol-mediated drug attachment to targeting peptides
09/22/2004EP1459768A2 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
09/22/2004EP1458416A1 Treatment of osteomyelitis with radiopharmaceuticals
09/22/2004EP1096955B1 Uses of antibodies to aminophospholipids for cancer treatment
09/22/2004EP1069888B1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
09/22/2004EP0929319B1 Dopamine and serotonin transporter ligands and imaging agents
09/22/2004EP0737207B1 Inhibitors of human plasmin derived from the kunitz domains
09/22/2004CN1531554A Humanized antibodies derived from DD-3B6-22, specific for D-dimer fragment of fibrin
09/22/2004CN1531526A Diaminedithiol derivatives and radiorhenium or radoitechnetium complex thereof; liver cancer-treating composition comprising radiorhenium complex and lipiodol; and kit for preparation of liver cancer
09/22/2004CN1531445A Biotin-derivatives and their conjugates with chelating agents
09/22/2004CN1531439A Liposome targeting of matrix metalloproteinase inhibitors
09/21/2004US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells
09/21/2004US6793798 Radioactively coated devices
09/21/2004CA2146757C Stabilization of fluorocarbon emulsions
09/16/2004WO2004079751A2 Method for producing actinium-225
09/16/2004WO2004078914A2 A fluorinase enzyme and use thereof in fluorination synthesis
09/16/2004WO2004078778A2 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
09/16/2004WO2004078146A2 Trans-membrane-antibody induced inhibition of apoptosis
09/16/2004WO2004032975A3 Biphenyls and fluorenes as imaging agents in alzheimer's disease
09/16/2004WO2004013180A3 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
09/16/2004WO2003104432A3 Anti-cd30 stalk and anti-cd30 antibodies suitable for use in immunotoxins
09/16/2004WO2003088898A3 Compositions and methods for the diagnosis and treatment of tumor
09/16/2004US20040180943 Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis
09/16/2004US20040180834 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
09/16/2004US20040180059 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject
09/16/2004US20040180001 antitumor
09/16/2004CA2518119A1 Trans-membrane-antibody induced inhibition of apoptosis
09/16/2004CA2517939A1 Peptides that specifically bind hgf receptor (cmet) and uses thereof
09/16/2004CA2516697A1 Method for producing actinium-225
09/15/2004EP1457483A1 Cationic lipids with serine backbone
09/15/2004EP1456386A2 Polycistronic expression of antibodies
09/15/2004EP1418808A4 Imaging marker transgenes
09/15/2004EP1287016B1 Radioimaging probes and the use thereof
09/15/2004EP1185526B1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
09/15/2004EP1089965B1 Urea derivatives for pain management
09/15/2004CN1528743A Fluoro labelled aliphatic acid myocardial metabolic imaging agent 14 (R,S)-Fluoro[18F]-6-thio cydonic acid purifying method
09/15/2004CN1528731A Aliphatic acid metabolic imaging agent beta-methyl-15-parafluoro [18F] phenyl-pentadecanoic acid and synthesizing method thereof
09/14/2004US6790843 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof
09/10/2004WO2004076449A2 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
09/10/2004WO2004075926A1 Radiolabelled substrates
09/10/2004WO2004075882A1 Methods of preventing, treating and diagnosing disorders of protein aggregation
09/10/2004WO2004075819A2 Activation and production of radiolabeled particles
09/10/2004WO2004042360A3 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
09/10/2004CA2519349A1 Activation and production of radiolabeled particles
09/10/2004CA2516953A1 Radiolabelled substrates
09/10/2004CA2516563A1 Methods of preventing, treating and diagnosing disorders of protein aggregation
09/09/2004US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
09/09/2004US20040176326 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
09/09/2004US20040176278 B-superfamily conotoxins
09/09/2004US20040175329 Method for continuous visualization of a body lumen
09/08/2004EP1455364A1 Method for producing actinium-225
09/08/2004EP1454137A2 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations
09/08/2004EP1453841A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them
09/08/2004EP1453525A1 Selective targeting of apoptotic cells
09/08/2004EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
09/08/2004CN1527727A Improved chelator conjugates
09/08/2004CN1526451A AIDS-resisting biological missile of internal radiating radium nuclein